Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyArizona Complete Health clinical trials Coverage |…
    Ask Trek AI about this page
    CurrentArizona Complete HealthPolicy CP.MP.94

    Clinical Policy: Clinical Trials

    Customize your policy alerts

    Sign up for Arizona Complete Health Policy CP.MP.94 alerts

    Get alerted when Policy CP.MP.94 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity and coverage for routine costs and management of complications for members/enrollees participating in qualifying clinical trials for Arizona Complete Health (Centene-affiliated plans). Applies to providers submitting claims or prior authorizations for trial-related routine care.

    Policy Summary
    PayerArizona Complete Health
    PolicyClinical Policy: Clinical Trials
    Policy CodePolicy CP.MP.94
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain and retain documentation that the clinical trial is qualifying (written protocol, IRB approval, and applicable federal or recognized approval) and follow prior-authorization and notification requirements per the plan.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    I–DPolicy sections defining scope
    3Excluded cost categories
    9

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Approving entities listed
    2025References through

    Coverage Criteria for Routine Clinical Trial Costs

    Covered routine clinical trial costs

    Covered when ALL of the following are met:

    Qualifying Routine Costs: Routine costs are covered if they are items or services generally considered medically necessary and a covered benefit provided in either the experimental or control arms, including: (1) items or services that are typically provided absent a clinical trial; (2) items or services required solely for the provision of the investigational item/service, for clinically appropriate monitoring of the effects of the item/service, or for prevention of complications; and (3) items or services needed for reasonable and necessary care arising from the provision of an investigational item/service, including diagnosis or treatment of complications.

    Based on policy section I.A (chunk 2).

    Qualifying Trial Requirements: The clinical trial must: have a written protocol describing a scientifically sound study and be approved by all relevant institutional review boards (IRBs); evaluate an item or service that falls within a covered benefit category; have therapeutic intent (not solely designed to test toxicity or disease pathophysiology); enroll appropriate patients for therapeutic trials (patients with the diagnosed disease) while diagnostic trials may enroll healthy controls; and be federally funded or approved by a listed entity (AHRQ, CDC, CMS, NIH, cooperative groups, VA/DoD/DoE peer-reviewed approvals, FDA IND-reviewed studies, or certain exempt drug trials).

    Based on policy sections I.D.1 and CLINICAL POLICY criteria (chunks 2 and 3).

    Administrative and Utilization Limits: All applicable Plan limitations for out-of-network care apply, and all existing utilization management guidelines (including prior-authorization and notification requirements) apply to routine care for members/enrollees in clinical trials.

    Based on policy section I.C (chunk 2).

    This policy excludes coverage for investigational items or services and certain research-only costs. Specifically, the following are not covered: (1) the investigational item or service itself; (2) items and services provided solely to satisfy data collection and analysis needs that are not used in the direct clinical management of the patient (for example, repeated imaging performed only for study data when clinically a single scan would suffice); and (3) items and services customarily provided by the research sponsor at no charge to trial enrollees. Claims for these excluded costs may be denied under the Plan’s coverage rules.

    Definitions

    inv-08: Routine costs in a clinical trial
    DefinitionItems and services generally considered medically necessary and a covered benefit that are provided in either the experimental or control arms of a qualifying clinical trial.
    Typical services provided absent a trialItems or services that are typically provided absent a clinical trial.
    Services for provision or monitoring of investigational itemItems or services required solely for the provision of the investigational item or service (e.g., administration of a non-covered chemotherapy agent) and clinically appropriate monitoring of the effects of the item or service.
    Care for complicationsItems or services needed for reasonable and necessary care arising from the provision of an investigational item or service, specifically for diagnosis or treatment of complications.
    inv-09: Excluded costs/services
    Investigational item/service

    Provider Actions, Documentation, and Billing Requirements

    Prior Authorization

    Prior authorization and notification required per plan

    All existing utilization management guidelines apply to routine care for members/enrollees in clinical trials, including prior-authorization and notification requirements.

    Step Therapy

    Utilization and network limitations apply

    Plan limitations for out-of-network care and existing utilization management (including prior authorization and notification) apply to routine clinical trial care and claims.

    Documentation Required

    Document qualifying trial and approvals

    Background

    This policy defines routine costs in a clinical trial as items and services that are generally considered medically necessary and are a covered benefit when provided in either the experimental or control arms. Routine costs include: (1) services that would typically be provided absent a clinical trial; (2) services required solely for the provision or clinically appropriate monitoring of the investigational item or service (for example, administration of a non-covered chemotherapy agent or monitoring of its effects) or for prevention of complications; and (3) services needed for the reasonable and necessary diagnosis or treatment of complications arising from the investigational item or service. All applicable plan limitations and utilization management rules (including prior authorization and network restrictions) continue to apply to these routine costs, and providers must document that the trial meets qualifying trial requirements described in the policy.

    Policy Summary
    PayerArizona Complete Health
    PolicyClinical Policy: Clinical Trials
    Policy CodePolicy CP.MP.94
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain and retain documentation that the clinical trial is qualifying (written protocol, IRB approval, and applicable federal or recognized approval) and follow prior-authorization and notification requirements per the plan.
    SourceLink
    On This Page
    Coverage Criteria for Routine Clinical Trial CostsDefinitionsProvider Actions, Documentation, and Billing RequirementsBackground
    The investigational item or service itself is excluded.
    Data-collection–only servicesItems and services provided solely to satisfy data collection and analysis needs that are not used in the direct clinical management of the patient (e.g., monthly CT scans when only a single scan is usually required).
    Sponsor‑provided itemsItems and services customarily provided by the research sponsors free of charge for any enrollee in the trial are excluded.

    Providers must have documentation that the clinical trial meets qualifying trial requirements, including a written protocol approved by relevant institutional review boards and that the trial evaluates an item/service within a covered benefit category with appropriate funding or approvals.

    • Written study protocol approved by all relevant IRBs (chunk 2).
    • Trial subject evaluates an item/service within a covered benefit category (chunk 3).
    • Evidence of federal funding or approval by listed entities (AHRQ, CDC, CMS, NIH, cooperative groups, VA/DoD/DoE peer review, FDA IND, or exempt drug trials) (chunk 3).
    Denial Risk

    Excluded costs may trigger denial

    Claims for the investigational item/service itself, services provided solely for data collection not used in direct clinical management, or items customarily provided free by research sponsors are excluded and may be denied.

    • The investigational item or service itself (chunk 2).
    • Items/services provided solely to satisfy data collection and analysis needs not used in direct clinical management (chunk 2).
    • Items/services customarily provided by research sponsors free of charge for any enrollee (chunk 2).